Journal of Cell Science & Therapy
Open Access

ISSN: 2157-7013

+44 1300 500008

Journal of Cell Science & Therapy : Citations & Metrics Report

Articles published in Journal of Cell Science & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Cell Science & Therapy has got h-index 17, which means every article in Journal of Cell Science & Therapy has got 17 average citations.

Following are the list of articles that have cited the articles published in Journal of Cell Science & Therapy.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total published articles	58	54	60	54	22	4	8	20	27	54	45	16	43	23	2
Research, Review articles and Editorials	1	3	4	19	10	3	5	18	18	38	34	16	39	21	2
Research communications, Review communications, Editorial communications, Case reports and Commentary	47	51	56	25	12	1	3	2	9	16	11	0	4	2	0
Conference proceedings	0	13	42	0	0	54	115	62	70	99	230	132	86	172	0
Citations received as per Google Scholar, other indexing platforms and portals	96	154	171	199	172	155	159	147	128	90	35	28	14	23	0

Journal total citations count	1608
Journal impact factor	2.87
Journal 5 years impact factor	5.10
Journal cite score	5.53
Journal h-index	17
Journal h-index since 2019	13

Important citations (712)

Expression and production of recombinant scorpine as a potassium channel blocker protein in escherichia coli. View at Publisher View at Google Scholar View at Indexing
Design and characterization of a novel tool for the antigenic enrichment of actinobacillus pleuropneumoniae outer membrane. View at Publisher View at Google Scholar View at Indexing
Widely applicable background depletion step enables transaminase evolution through solid-phase screening. View at Publisher View at Google Scholar View at Indexing
Teaching an old pet new tricks: tuning of inclusion body formation and properties by a mixed feed system in e. coli. View at Publisher View at Google Scholar View at Indexing
High-throughput recombinant protein expression in escherichia coli: current status and future perspectives. View at Publisher View at Google Scholar View at Indexing
Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor? View at Publisher View at Google Scholar View at Indexing
Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters. View at Publisher View at Google Scholar View at Indexing
Genomic and rapid effects of aldosterone: what we know and do not know thus far. View at Publisher View at Google Scholar View at Indexing
Challenges in drug discovery against tuberculosis View at Publisher View at Google Scholar View at Indexing
Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in east wollega, western ethiopia. View at Publisher View at Google Scholar View at Indexing
In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant mycobacterium tuberculosis. View at Publisher View at Google Scholar View at Indexing
Congenital malformations of the lung. View at Publisher View at Google Scholar View at Indexing
Pictorial review of false-positive results on radioiodine scintigrams of patients with differentiated thyroid cancer. View at Publisher View at Google Scholar View at Indexing
Date palm fruit extract ameliorated pancreatic apoptosis, endocrine dysfunction, and regulatory inflammatory cytokines in streptozotocin-induced diabetes in rats. View at Publisher View at Google Scholar View at Indexing
Metcam/muc18 promotes tumor progression and metastasis in most human cancers. View at Publisher View at Google Scholar View at Indexing
Dual role of metcam/muc18 expression in the progression of cancer cells View at Publisher View at Google Scholar View at Indexing
Human metcam/muc18 is a new diagnostic marker of and a driver for promoting and its specific sirnas, derived oligopeptides and antibodies be used for decreasing the malignant progression of prostate cancer. View at Publisher View at Google Scholar View at Indexing
Metcam/muc18: a novel tumor suppressor for some cancers. View at Publisher View at Google Scholar View at Indexing
Validating metcam/muc18 as a novel biomarker to predict the malignant potential of prostate cancer at an early stage by using a modified gold nanoparticles-based lateral flow immunoassay. View at Publisher View at Google Scholar View at Indexing
Metcam/muc18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: validation with western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 ... 20 21 22 23 24 25 26 27 28 29 30 ... 35 36 Next »

Top